AREV Life Sciences Global Corp. (AREVF)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jan 29, 2026

AREV Life Sciences Global Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Net Income
-0.24-1.44-0.99-1.05-3.19-8.27
Depreciation & Amortization
0.070.130.150.150.070.05
Other Amortization
---00.030.02
Loss (Gain) From Sale of Assets
---0.06--
Asset Writedown & Restructuring Costs
---0.21.086.63
Loss (Gain) From Sale of Investments
---0.08--
Stock-Based Compensation
-0.170.140.460.111.190.62
Provision & Write-off of Bad Debts
00--0.04-
Other Operating Activities
0.010.04-0.710.010.050.04
Change in Accounts Receivable
-0.010.08-0-0-0.030.01
Change in Inventory
---0.02-0--
Change in Accounts Payable
-0.110.560.150.180.36-0.22
Change in Other Net Operating Assets
0.290.22-0.50.250.290
Operating Cash Flow
-0.15-0.28-1.47-0.02-0.11-1.1
Capital Expenditures
0.01-0.03-0.01-0.31-0.22-
Sale of Property, Plant & Equipment
--0.06---
Sale (Purchase) of Intangibles
----0.1--0.05
Other Investing Activities
-0.05-0.05-0.05-0.03--
Investing Cash Flow
-0.04-0.08-0.01-0.44-0.22-0.58
Short-Term Debt Issued
-0.010.31-0.1-
Total Debt Issued
0.110.010.31-0.1-
Long-Term Debt Repaid
----0.05--
Total Debt Repaid
0.04---0.05--
Net Debt Issued (Repaid)
0.150.010.31-0.050.1-
Issuance of Common Stock
0.030.21.020.730.250.63
Other Financing Activities
---0.05--
Financing Cash Flow
0.180.211.340.730.350.63
Foreign Exchange Rate Adjustments
-000-00
Net Cash Flow
-0.01-0.16-0.140.270.02-1.05
Free Cash Flow
-0.14-0.31-1.48-0.33-0.33-1.1
Free Cash Flow Margin
-1931.00%-633.36%-581.17%-174.04%-168.90%-
Free Cash Flow Per Share
-0.00-0.01-0.08-0.02-0.04-0.17
Levered Free Cash Flow
-0.080.02-0.63-0.650.2-1.13
Unlevered Free Cash Flow
-0.080.02-0.6-0.620.22-1.13
Change in Working Capital
0.170.85-0.370.420.62-0.2
Updated Dec 8, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.